Journal ArticleDOI
Adolescent and young adult HPV vaccination in Australia: achievements and challenges.
Reads0
Chats0
TLDR
Since the vaccination program was initiated, a reduction in new cases of genital warts of 73% among vaccine eligible age females has been evidenced in STI clinics across Australia and a reduction of 44% of new cases in young males was also documented during this same time period, suggesting significant herd immunity.About:
This article is published in Preventive Medicine.The article was published on 2011-10-01. It has received 77 citations till now. The article focuses on the topics: Genital warts & Vaccination.read more
Citations
More filters
Journal ArticleDOI
Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
Ahmedin Jemal,Edgar P. Simard,Christina G. Dorell,Anne-Michelle Noone,Lauri E. Markowitz,Betsy A. Kohler,Christie R. Eheman,Mona Saraiya,Priti Bandi,Debbie Saslow,Kathleen A. Cronin,Meg Watson,Mark Schiffman,S. Jane Henley,Maria J. Schymura,Robert N. Anderson,David Yankey,Brenda K. Edwards +17 more
TL;DR: The overall trends in declining cancer death rates continue, however, increases in incidence rates for some HPV-associated cancers and low vaccination coverage among adolescents underscore the need for additional prevention efforts for HPV- associated cancers, including efforts to increase vaccination coverage.
Journal ArticleDOI
Human papillomavirus and cervical cancer.
TL;DR: More sensitive than cytology, primary screening by human papillomavirus testing could enable screening intervals to be extended and if these prevention strategies can be implemented in developing countries, many thousands of lives could be saved.
Journal ArticleDOI
Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data
Hammad Ali,Basil Donovan,Basil Donovan,Handan Wand,Tim R H Read,David G. Regan,Andrew E. Grulich,Christopher K Fairley,Rebecca Guy +8 more
TL;DR: The significant declines in the proportion of young women found to have genital wart and the absence of genital warts in vaccinated women in 2011 suggests that the human papillomavirus vaccine has a high efficacy outside of the trial setting.
Journal ArticleDOI
Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation.
Gregory D. Zimet,Zeev Rosberger,Zeev Rosberger,William A. Fisher,Samara Perez,Samara Perez,Nathan W. Stupiansky +6 more
TL;DR: Most fears related to HPV vaccine are more related to myth than reality and it will be essential to focus on the education of HCPs regarding indications for HPV vaccination and approaches to communicating most effectively with parents and patients.
Journal ArticleDOI
Valuing vaccination
Till Bärnighausen,Till Bärnighausen,David E. Bloom,Elizabeth T. Cafiero-Fonseca,Jennifer C. O’Brien +4 more
TL;DR: A framework for conceptualizing the full benefits of vaccination is set forth, including avoided medical care costs, outcome-related productivity gains, behavior-related productive gains, community health Externalities, community economic externalities, and the value of risk reduction and pure health gains.
References
More filters
Journal ArticleDOI
Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine
Suzanne M. Garland,Marc Steben,Heather L. Sings,Margaret K. James,Shuang Lu,Radha Railkar,Eliav Barr,Richard M. Haupt,Elmar A. Joura +8 more
TL;DR: The major role played by HPV-6 and HPV-11 in GW is confirmed, as well as associated risk factors, and a vaccine that includes these types of HPV could substantially reduce the overall burden of HPV disease.
Journal ArticleDOI
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
Julia M.L. Brotherton,Masha Fridman,Cathryn L May,Genevieve Chappell,A Marion Saville,Dorota M. Gertig +5 more
TL;DR: This is the first report of a decrease in incidence of HGAs within 3 years after the implementation of a population-wide HPV vaccination programme in Victoria, Australia.
Journal ArticleDOI
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.
Barbara A. Slade,Laura Leidel,Claudia Vellozzi,Emily Jane Woo,Wei Hua,Andrea Sutherland,Hector S. Izurieta,Robert Ball,Nancy Miller,M. Miles Braun,Lauri E. Markowitz,John K. Iskander +11 more
TL;DR: Most of the AEFI rates were not greater than the background rates compared with other vaccines, but there was disproportional reporting of syncope and venous thromboembolic events.
Journal ArticleDOI
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
Basil Donovan,Neil Franklin,Rebecca Guy,Andrew E. Grulich,David G. Regan,Hammad Ali,Handan Wand,Christopher K Fairley +7 more
TL;DR: The decrease in frequency of genital warts in young Australian women resulting from the high coverage of HPV vaccination might provide protective effects in heterosexual men through herd immunity.
Journal ArticleDOI
Guidelines for adolescent preventive services (GAPS).
TL;DR: Although the performance of a physical examination at each of these visits has been questioned with regard to its limited value, the clinical interview and opportunity for risk assessment that appears to yield significant opportunities to promote preventive health measures.
Related Papers (5)
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
Luisa L. Villa,Gonzalo Perez,Susanne K. Kjaer,Jorma Paavonen,Matti Lehtinen,Nubia Muñoz,Kristjan Sigurdsson,Mauricio Hernández-Ávila,Finn Egil Skjeldestad,Steinar Thoresen,Patricia J. Garcia,Slawomir Majewski,Joakim Dillner,Sven Eric Olsson,Hseon Tay Eng,F. Xavier Bosch,Kevin A. Ault,Darron R. Brown,Daron G. Ferris,Laura A. Koutsky,Robert J. Kurman,Evan R. Myers,Eliav Barr,John W. Boslego,Janine T. Bryan,Mark T. Esser,Christine K. Gause,Teresa M. Hesley,Lisa Lupinacci,Heather L. Sings,Frank J. Taddeo,Annemarie R. Thornton +31 more
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
Suzanne M. Garland,Suzanne M. Garland,Mauricio Hernández-Ávila,Cosette M. Wheeler,Gonzalo Perez,Diane M. Harper,Sepp Leodolter,Grace W.K. Tang,Daron G. Ferris,Marc Steben,Janine T. Bryan,Frank J. Taddeo,Radha Railkar,Mark T. Esser,Heather L. Sings,Micki Nelson,John W. Boslego,Carlos Sattler,Eliav Barr,Laura A. Koutsky +19 more
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Matti Lehtinen,Jorma Paavonen,Cosette M. Wheeler,Unnop Jaisamrarn,Suzanne M. Garland,Xavier Castellsagué,S. Rachel Skinner,Dan Apter,Paulo Naud,Jorge Salmerón,Song Nan Chow,Henry C Kitchener,Julio Cesar Teixeira,James Hedrick,Genara Limson,Anne Szarewski,Barbara Romanowski,Fred Y. Aoki,Tino F. Schwarz,Willy Poppe,Newton Sérgio de Carvalho,Maria Julieta V Germar,Klaus Peters,Adrian Mindel,Philippe De Sutter,F. Xavier Bosch,Marie Pierre David,Dominique Descamps,Frank Struyf,Gary Dubin +29 more
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
Jorma Paavonen,Paulo Naud,Jorge Salmerón,Cosette M. Wheeler,Song-Nan Chow,D Apter,Henry C Kitchener,Xavier Castellsagué,Julio Cesar Teixeira,S R Skinner,James Hedrick,Unnop Jaisamrarn,Genara Limson,Suzanne M. Garland,Anne Szarewski,Barbara Romanowski,Fred Y. Aoki,Tino F. Schwarz,Willy Poppe,Franz X. Bosch,David Jenkins,Karin Hardt,Toufik Zahaf,Dominique Descamps,Frank Struyf,Matti Lehtinen,Gary Dubin +26 more